Banff 2003 meeting report: new diagnostic insights and standards

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Lorraine C RacusenKim Solez

Abstract

The Seventh Banff Conference on Allograft Pathology was held June 14-18, 2003 in Aberdeen, Scotland representing the latest iteration of the international consensus meeting, which develops worldwide standards for interpretation of allograft biopsies. The meeting is an important force behind standardized slide interpretation to strengthen endpoints in international clinical trials. Of participants polled 87% reported that they would alter clinical practice as a direct consequence of the meeting and its content. Advances were made in many areas including tubulitis mechanisms, real-time polymerase chain reaction (PCR) gene analysis and microarrays in rejection diagnosis, tolerance/accommodation/immunomodulation, the role of monocytes and macrophages in rejection and C4d as a marker for antibody-mediated rejection. A provisional scoring system for peritubular capillary inflammatory cell accumulation in antibody-mediated rejection was presented for testing, as well as plans for a nephrectomy study to determine specificity of vascular lesions of rejection. Future meetings are planned for 2005 (Edmonton), 2007 and 2009, with active ongoing Internet discussion between meetings.

References

Sep 1, 1997·The Journal of Clinical Investigation·M TakadaN L Tilney
Sep 12, 2000·The American Journal of Pathology·J R PrattS H Sacks
Jun 4, 2002·Nature Medicine·Julian R PrattSteven H Sacks
Jun 5, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Lorraine C RacusenKiril Trpkov
Nov 25, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Wolfram J JabsPhilip F Halloran

❮ Previous
Next ❯

Citations

Feb 18, 2011·Der Pathologe·K AmannH Schöcklmann
Apr 26, 2011·International Urology and Nephrology·Minmin WangJianghua Chen
May 28, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Paolo CravediRoslyn B Mannon
Jun 30, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Uta ErdbrueggerWilfried Gwinner
Oct 6, 2005·Current Opinion in Nephrology and Hypertension·Helmut E Feucht, Michael J Mihatsch
May 15, 2007·Transplantation·Stanislas FaguerLionel Rostaing
Nov 17, 2010·Transplantation·Zhu LanHao Wang
May 2, 2013·Transplantation·Christina DörjeAnna Varberg Reisæter
Jun 13, 2013·Transplantation·Tara K SigdelMinnie M Sarwal
Jun 28, 2013·Transplantation·Christoph MetalidisDirk R J Kuypers
Mar 5, 2008·Nephrology·Sze K YuenKwok L Tong
Jun 26, 2013·American Journal of Nephrology·Naim IssaHassan N Ibrahim
Dec 18, 2010·Journal of the American Society of Nephrology : JASN·Markus WahrmannGeorg A Böhmig
Jan 19, 2012·Molecular Medicine·Hernandez M SilvaVerônica Coelho
Feb 13, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Petra GlanderKlemens Budde
Jan 22, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Balsam El GhoulFadi Fakhouri
Jan 15, 2005·Free Radical Biology & Medicine·Niels Olsen Saraiva Camara, Miguel Parreira Soares
Oct 15, 2005·Transplant Immunology·D N IonescuS A Yousem
May 31, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Antoine ThierryGuy Touchard
Apr 6, 2016·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Deborah J LevineAdriana Zeevi
Nov 12, 2013·The Surgical Clinics of North America·Lillian W GaberSamir J Patel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Kim SolezM Valente
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Lorraine C RacusenK Trpkov
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Kim SolezJ J Weening
© 2021 Meta ULC. All rights reserved